Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06853626

Improved Management of Acute Chest Pain in Emergency Primary Care Using the QuidelOrtho TriageTrue High-Sensitivity Point-of-Care Troponin Assay

Led by University of Oslo · Updated on 2025-12-10

2500

Participants Needed

6

Research Sites

156 weeks

Total Duration

On this page

Sponsors

U

University of Oslo

Lead Sponsor

N

Norwegian Health Association

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a new method to manage acute chest pain in emergency primary care settings, focusing on the use of a high-sensitivity point-of-care troponin test. This test aims to improve diagnosis and reduce unnecessary hospital referrals for chest pain, which is often not related to heart problems. The study is sponsored by the University of Oslo and involves 2,500 patients over 1.5 years. Participants will have a blood sample taken for testing with the QuidelOrtho TriageTrue hs-cTnI whole-blood assay. Physicians will use a specific 0/1-hour algorithm to interpret results and guide decisions. This approach will be compared to standard care to assess its clinical performance and impact on hospital referrals and healthcare use. During the study, participants will be monitored for acute myocardial infarction occurrences and quality of life changes, including psychological stress and anxiety, using validated questionnaires at baseline and after 90 days. Researchers will also track hospital referrals, length of stay, and healthcare costs up to one year. The total involvement includes initial testing and follow-up assessments to evaluate the new testing strategy's effect on patient outcomes and healthcare efficiency.

CONDITIONS

Brief Title

One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients 18 years or older with non-traumatic acute chest pain presenting in emergency primary care
  • Troponin testing requested by the treating physician
Not Eligible

You will not qualify if you...

  • Acute STEMI requiring direct hospital referral
  • Hemodynamically unstable patients requiring immediate hospital referral
  • Unable to provide written informed consent due to time restraints, language barriers, cognitive impairment, or other reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - Up to 1 hour

Participants have a venous blood sample taken for high-sensitivity troponin testing using the QuidelOrthos TriageTrue whole-blood point-of-care assay. The treating physician evaluates results using a specific 0/1-hour algorithm.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 1 year

Participants are followed for outcomes related to acute myocardial infarction, hospital referrals, and health-related quality of life over time.

Follow-up assessments at baseline, 30 days, 90 days, and 1 year

Trial Site Locations

Total: 6 locations

1

Lyngen Emergency Primary Care Centre

Lyngseidet, Lyngen, Norway

Actively Recruiting

2

Alta Emergency Primary Care Centre

Alta, Norway

Actively Recruiting

3

Drammen Emergency Primary Care Centre

Drammen, Norway

Actively Recruiting

4

Fredrikstad and Hvaler Emergency Primary Care Centre

Fredrikstad, Norway

Actively Recruiting

5

Oslo Accident and Emergency Outpatient Clinic

Oslo, Norway

Actively Recruiting

6

Trondheim Intermunicipal Emergency Primary Care Centre

Trondheim, Norway

Actively Recruiting

Loading map...

Research Team

T

Tonje R. Johannessen, MD, PhD

O

Odd Martin Vallersnes, Professor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

Clinical Cohort Registry Study on Primary PCI for Acute Myoc...

Acute Myocardial Infarction (AMI)

Actively Recruiting

1 location

Analysis of the Relationship Between Growth Differentiation ...

Acute Coronary Syndromes (ACS)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

One-Hour Troponin Using a High-Sensitivity Point-of-Care Assay in Emergency Primary Care: The OUT-POC Pilot Study.

Tonje R Johannessen, Odd Martin Vallersnes, Anne Cecilie K Larstorp...

https://pubmed.ncbi.nlm.nih.gov/40058362

Authors' Response Letter - Expanding the Use of Point-of-Care hs-cTnI in Emergency Primary Care: Insights from the OUT-POC Pilot Study.

Tonje R Johannessen, Odd Martin Vallersnes, Anne Cecilie K Larstorp...

https://pubmed.ncbi.nlm.nih.gov/40418919